Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.
TESTING THE AGILE DATABASE FOR AN EXTERNAL VALIDATION OF A NOMOGRAM TO PREDICT MALIGNANCY OR AGGRESSIVENESS OF RENAL MASSES, BASED ON RENAL SCORE / Antonelli, A.; Minervini, A.; Cindolo, L.; Porreca, A.; Crivellaro, S.; Parma, P.; Zaramella, S.; Rocco, B.; Bove, P.; Pagliarulo, V.; Celiall, A.; Ceruti, C.; Falsaperla, M.; Nuciotti, R.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 33:(2005), pp. 2312-2313.
TESTING THE AGILE DATABASE FOR AN EXTERNAL VALIDATION OF A NOMOGRAM TO PREDICT MALIGNANCY OR AGGRESSIVENESS OF RENAL MASSES, BASED ON RENAL SCORE
Antonelli, A.;Rocco, B.;
2005
Abstract
Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
